|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.29/-0.93
|
企業價值
37.11M
|
資產負債 |
每股賬面淨值
5.54
|
現金流量 |
現金流量率
--
|
損益表 |
收益
196.00K
|
每股收益
0.01
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/12/24 13:08 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. |